Spectrum Pharmaceuticals, Inc.
COMBINATION OF POZIOTINIB WITH CYTOTOXIC AGENT AND/OR OTHER MOLECULARLY TARGETED AGENT AND USE THEREOF

Abstract:

Provided are a combination of poziotinib and at least one agent selected from the group consisting of cytotoxic agents and molecularly targeted agents; and a use of the combination.